Research and Markets: The Global Pain Therapeutics Market, 3rd Edition - Market Analysis, R&D Pipelines and Competitive Landscape

Business Wire, March 19, 2009

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/bf38da/the_global_pain_th) has announced the addition of the "The Global Pain Therapeutics Market, 3rd Edition - Market Analysis, R&D Pipelines and Competitive Landscape" report to their offering.

Overview

One in five people suffer from moderate to severe chronic pain, and one in three is unable or less able to maintain an independent lifestyle due to their pain. Between 50 and 60 percent of people with chronic pain are less able or unable to exercise, sleep normally, perform household chores, attend social activities, drive a car, or walk.

The value of the pharmaceutical market for pain relief in 2008 reflects this seeming worldwide epidemic of pain. The Global Pain Therapeutics Market assesses key pain management therapeutics - such as opioids, triptans, anticonvulsants, Cox-II inhibitors and traditional NSAIDs and are discussed in terms of their past, present and future value and the role they are playing in the effective management of pain. This report discusses the key products within each of these areas and outlines the drivers of these markets as well as the restraints on them.

The Global Pain Therapeutics Market also identifies and discusses trends and issues that will have a significant impact on the pain management market and profiles the leading companies in the field. The report provides the reader with valuable information and analysis regarding key products on the market and in clinical development.

Key features and highlights of this report:

• Extensive review of key products indicated for pain conditions and their market value and impact
• Discussion of the key drivers of and restraints on the global pain therapeutics market
• Qualitative analysis of key pain markets and products driving growth (opioids, NSAIDs, triptans, neuropathic pain therapies (anticonvulsants) and Cox-II inhibitors)
• Profiles and reviews of key pipeline products in development for fibromyalgia, cancer pain, post-operative pain, migraine pain, neuropathic pain and opioid therapies
• Profiles of nearly 100 companies engaged in the development and/or commercialization of pain therapeutics worldwide
• Overviews of treatment options for post-operative pain, migraine pain, cancer pain, fibromyalgia, arthritic pain, back pain, neuropathic pain, and the demographic impact of these conditions.
• Chapter devoted to the role of drug delivery technologies in the current and future treatment of pain
• Discussion of promising areas of research in a variety of pain areas and companies engaged in cutting edge research and development

Key Topics Covered:

• 1 METHODOLOGY AND EXECUTIVE SUMMARY
• 2 CAUSES, CLASSIFICATIONS AND GLOBAL IMPACT OF PAIN
• 3 TREATING PAIN: DRUG CLASSES AND GUIDELINES
• 4 POST-OPERATIVE PAIN OVERVIEW AND THERAPEUTICS OPTIONS
• 5 BACK PAIN OVERVIEW AND THERAPEUTIC OPTIONS
• 6 NEUROPATHIC PAIN OVERVIEW AND THERAPEUTIC OPTIONS
• 7 MIGRAINE OVERVIEW AND THERAPEUTIC OPTIONS
• 8 CANCER PAIN OVERVIEW AND THERAPEUTIC OPTIONS
• 9 ARTHRITIC PAIN OVERVIEW AND THERAPEUTIC OPTIONS
• 10 FIBROMYALGIA OVERVIEW AND THERAPEUTIC OPTIONS
• 11 NON-PHARMACEUTICAL PAIN TREATMENT
• 12 NSAID USE AND MARKET ANALYSIS
• 13 OPIOID USE AND MARKET TRENDS
• 14 TRIPTANS THERAPY MARKET
• 15 ANTICONVULSANT MARKET
• 16 COX-2 INHIBITORS AND THE FUTURE
• 17 PRODUCTS IN DEVELOPMENT
• 18 THE ROLE OF DRUG DELIVERY IN EMERGING PAIN THERAPEUTICS
• 19 PROMISING AREAS OF RESEARCH
• 20 COMPANY BRIEFS
• TABLES AND GRAPHS

For more information visit http://www.researchandmarkets.com/research/bf38da/the_global_pain_th